Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease-Reference-Cited by-同舟云学术

Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease

Published:2017-01-09 Issue:1 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Diana Andrea¹,Pillai Rita¹,Bongioanni Paolo²,O'Keeffe Aidan G³,Miller Robert G⁴,Moore Dan H⁵

Affiliation:

1. University of Cagliari; Department of Biomedical Sciences; Citta Universitaria di Monserrato (Cagliari) Monserrato (Cagliari) Italy 09042

2. University of Pisa; Neurorehabilitation Unit, Department of Neuroscience; Via Paradisa, 2 Pisa Italy 56100

3. University College London; Department of Statistical Science; 1-19 Torrington Place London UK WC1E 6BT

4. California Pacific Medical Center; Forbes Norris ALS Research Center; 2324 Sacramento Street, Suite 150 San Francisco USA 94115

5. California Pacific Medical Center; Research Institute; 475 Brannan St Suite 220 San Francisco CA USA 94107

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group;Miller;Neurology,1996

2. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis;Miller;Neurology,2001

3. Pharmacologic reversal of cortical hyperexcitability in patients with ALS;Caramia;Neurology,2000

4. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy;Kalra;American Journal of Neuroradiology,2003

5. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis;Mazzini;Journal of the Neurological Sciences,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research and comparative assessment of bioaccumulation and negative effects during chronic inhalation exposure to nano- and microparticles of aluminum oxide in an experiment;Hygiene and sanitation;2024-07-17

2. Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a ‘real-world’ setting;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2024-07-07

3. Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night;CNS Neuroscience & Therapeutics;2024-03

4. How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?;Brain;2024-02-26

5. Pathological mechanisms of amyotrophic lateral sclerosis;Neural Regeneration Research;2023-08-14